Article
Canagliflozin alleviates LPS-induced acute lung injury by modulating alveolar macrophage polarization.
International immunopharmacology - 1 Nov 2020
Lin Fengyu, Song Chao, Zeng Yanjun, Li Yi, Li Haitao, Liu Ben, Dai Minhui, Pan Pinhua
Abstract excerpt
BACKGROUND: Canagliflozin (CANA), a sodium-glucose cotransporter 2 inhibitor, is a novel therapeutic agent that exhibits multiple actions in type 2 diabetes. CANA can regulate intracellular glucose metabolism and exert anti-inflammatory effects in immune cells. Alveolar macrophage polarization balance is often associated with lower inflammation in acute lung injury (ALI). However, little is known about the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
